BlackRock Japan’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

BlackRock Japan’s Portfolio SCMP Stock Details SCMP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$2K	Sell	162 -1,913	-92%	-$26.7K	﹤0.01%	1300
2016 Q3	$26K	Buy	2,075 +377	+22%	+$4.44K	﹤0.01%	1083
2016 Q2	$19K	Buy	+1,698	New	+$19K	﹤0.01%	1177
2016 Q1	–	Sell	-2,907	Closed	-$50K	–	1525
2015 Q4	$50K	Sell	2,907 -1,842	-39%	-$33K	﹤0.01%	1033
2015 Q3	$94K	Sell	4,749 -7,911	-62%	-$181K	﹤0.01%	875
2015 Q2	$208K	Sell	12,660 -4,618	-27%	-$80.1K	﹤0.01%	868
2015 Q1	$269K	Buy	17,278 +1,182	+7%	+$18.3K	﹤0.01%	835
2014 Q4	$230K	Buy	+16,096	New	+$170K	﹤0.01%	858

Other funds holding SCMP

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

KAM

Krensavage Asset Management New York $263M AUM 66.99% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Redwood Investments Boston, Massachusetts $267M AUM 11.99% 1-Year Est. Return

BlackRock Japan's SCMP Position: Q4 2016 in Review

BlackRock Japan reduced its Sucampo Pharmaceuticals, Inc. (SCMP) stake by 92% in Q4 2016, selling an estimated $26.7K and leaving 162 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #1300.

BlackRock Japan first reported a position in SCMP in Q4 2014 and has held it in 8 quarters since. The position peaked at $269K in Q1 2015. 165 funds tracked by Wall St. Rank hold SCMP as of Q4 2016.

BlackRock Japan held 162 shares of Sucampo Pharmaceuticals, Inc. worth $2K as of Q4 2016.
BlackRock Japan sold 1,913 Sucampo Pharmaceuticals, Inc. shares in Q4 2016, an estimated $26.7K.
Sucampo Pharmaceuticals, Inc. made up ﹤0.01% of BlackRock Japan's portfolio in Q4 2016, its #1300 holding.
BlackRock Japan first reported a position in Sucampo Pharmaceuticals, Inc. in Q4 2014 and has held it in 8 quarters since.
BlackRock Japan's Sucampo Pharmaceuticals, Inc. position peaked at $269K in Q1 2015.
165 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q4 2016.

Based on BlackRock Japan's 13F filing for Q4 2016, filed 10 Feb 2017.